5 • 644 Ratings
🗓️ 16 February 2016
⏱️ 28 minutes
🧾️ Download transcript
In this episode, we discuss nausea and vomiting of pregnancy (NVP) with a particular focus on Diclegis (doxylamine/pyridoxine).
Click on a timestamp to play from that location
0:00.0 | Welcome to Helix Talk, an educational podcast for healthcare students and providers covering real-life clinical pearls, professional pharmacy topics, and drug therapy discussions. |
0:11.0 | This podcast is provided by pharmacists and faculty members at Roslyn Franklin University College of Pharmacy. |
0:17.0 | This podcast contains general information for educational purposes only. This is not |
0:22.0 | professional advice and should not be used in lieu of obtaining advice from a qualified health |
0:26.3 | care provider. And now on to the show. Welcome to Helix Talk episode 39. I'm your co-host |
0:34.4 | Dr. Kane. I'm Dr. Schumann. And I'm Dr. Patel. So before we get into this week's episode, I just wanted to give a brief mention of something |
0:40.3 | that's pretty exciting here at Rosalind Franklin University. |
0:43.3 | Yes, indeed. |
0:44.3 | It's very exciting that two of our students, William Olegria and Haley Spouting, have placed |
0:49.3 | first place at the ASHP's Clinical skills competition where 129 schools competed. |
0:56.1 | And what this was, it was an interactive team-based analysis of a clinical scenario they |
1:00.6 | were given with patient labs, patient case, and what they were to do is come up with a care |
1:05.5 | plan there looking at a listing of different drug therapy problems, prioritizing them, |
1:10.4 | triaging the patient, as well as |
1:12.2 | potentially imagining a scenario where they would provide clinical collaborative practice for |
1:16.3 | physicians towards direct patient care. So again, congratulations. We're very proud of you, and we'll go |
1:21.5 | ahead and get into the show. Today we're talking briefly about nausea and vomiting of pregnancy |
1:26.2 | with a particular focus on a newer product |
1:29.0 | called DiClegious. |
1:30.3 | The historical perspective and DiCledges involves controversial lawsuits for the birth defects |
1:37.5 | causing the withdrawal from the market and then it was reapproved. |
1:40.9 | We're going to talk about how the statistical significant is only half the truth, |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Sean P. Kane, PharmD, BCPS, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Sean P. Kane, PharmD, BCPS and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.